Skip to main content

Glazer Capital, LLC

SEC CIK
0001076809
Latest filing
Aug 14, 2026

TPTX holding history

Turning Point Therapeutics, Inc. in every 13F filed by Glazer Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TPTX overviewAll 13F holders of TPTXFull Q2 2026 holdings

Shares (Q3 2022)
0
Sold out in Q3 2022
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q2 2022
Holdings of TPTX by Glazer Capital, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20220$00.0%−600,368−100.0%Sold outHolders
Q2 2022600,368$45.2M1.1%+600,368NewHolders